Metraipolis › archive › dc_b5ef83e98259
Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41930310
- DOI
- 10.1016/j.esmorw.2025.100659
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T01:06:15.827Z
- SHA-256 of the archived text
45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98- Stable URL of this page
https://metraipolis.com/documento/dc_b5ef83e98259
How to cite
Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310 — Europe PMC (en), https://europepmc.org/article/MED/41930310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ef83e98259 (Metraipolis archive dc_b5ef83e98259, sha256 45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98)
BibTeX
@misc{dcb5ef83e98259,
title = {Real-world outcomes following PARP inhibitor maintenance in ovarian cancer by BRCA status: a retrospective cohort study — Europe PMC PMID:41930310},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41930310},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ef83e98259; sha256 45e7a9562c2680313b6f052b1cd4120998865a2da30dca750899e8e02dd6da98},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930310. Agents can read the archived copy with the MCP tool read_document.